This federal contract award, valued at $6,738.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic domains.
The contract award does not have a set-aside designation, indicating open competition. As a major vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, AmerisourceBergen has established itself as a key supplier of pharmaceutical and medical products to various government agencies.
Generated 3/18/25, 9:55 AM